NET PROFIT (x1000 EUR)
EMPLOYEES
Jemo-Pharm A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-61
|
-142
|
38 |
| Total assets |
5,720
|
5,678
|
5,521 |
| Current assets |
3,968
|
3,991
|
3,730 |
| Current liabilities |
5,635
|
4,991
|
4,875 |
| Equity capital |
-21
|
-49
|
76 |
| - share capital |
54
|
54
|
54 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
-0.4%
|
-0.9%
|
1.4% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
70.4%
|
80.0%
|
76.5% |
| Return on equity (ROE) |
290.5%
|
289.8%
|
50.0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.